Sort by
Refine Your Search
-
Listed
-
Employer
- Radboud University
- Utrecht University
- Wageningen University & Research
- Eindhoven University of Technology (TU/e)
- Eindhoven University of Technology (TU/e); 4 Oct ’25 published
- Leiden University
- Leiden University; yesterday published
- Radboud University Medical Center (Radboudumc); Published yesterday
- University Medical Centre Groningen (UMCG); today published
- University of Amsterdam (UvA)
- Utrecht University; Published yesterday
- Wageningen University and Research Center
- 2 more »
- « less
-
Field
-
key role in (neuro)inflammatory disorders, and its writers and erasers are emerging as promising drug targets. Your job In this project, you will apply chemical proteomics strategies in cells and
-
PhD Position in Chemical Proteomics Faculty: Faculty of Science Department: Department of Chemistry Hours per week: 36 to 40 Application deadline: 24 November 2025 Apply now Protein lipidation
-
signalling and disease progression. The goal of the Oncode Accelerator Growth Fund project is to accelerate the development of new cancer therapies. In this PhD project, you will employ existing proteomic
-
to accelerate the development of new cancer therapies. In this PhD project, you will employ existing proteomic tools and develop new ones to study protein interactions and signalling pathways in
-
) the molecular mechanisms of how these components work together to govern dynamic regulation of specific cellular processes. Our innovative approach combines proteomics, biochemistry, and advanced imaging
-
, proteomics and advanced imaging. This research project will be executed in close collaboration with the Princess Máxima Center. Radboudumc Welcome to Radboud university medical center (Radboudumc), where
-
proteomics methods using mass spectrometry. Additionally, you will engineer full proteins and signature peptides for method development, calibration, and quality control. This work will provide the foundation
-
immunoextraction of full proteins and SISCAPA-based peptide extraction, and develop targeted bottom-up proteomics methods using mass spectrometry. Additionally, you will engineer full proteins and signature peptides
-
proteomic technologies and bioinformatics are used. We run Next Generation Sequencers, single-cell platforms and mass spectrometers, and accommodate a bioinformatics team and a local computational
-
first-class international research environment in the regulation of gene expression and epigenetics where state-of-the-art genomic and proteomic technologies and bioinformatics are used. We run Next